Pacific Hospital Supply Co., Ltd (4126.TWO)
TWD 90.3
(-2.38%)
TWD 90.3
(-2.38%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 241.73 Million TWD | 3.54% |
| 2022 | 233.47 Million TWD | 11.17% |
| 2021 | 210.01 Million TWD | -11.5% |
| 2020 | 237.29 Million TWD | 2.46% |
| 2019 | 231.6 Million TWD | 7.71% |
| 2018 | 215.02 Million TWD | 2.87% |
| 2017 | 209.02 Million TWD | -0.94% |
| 2016 | 211.01 Million TWD | 6.37% |
| 2015 | 198.38 Million TWD | 8.24% |
| 2014 | 183.28 Million TWD | 0.31% |
| 2013 | 182.72 Million TWD | 2.77% |
| 2012 | 177.8 Million TWD | 9.92% |
| 2011 | 161.75 Million TWD | 6.71% |
| 2010 | 151.58 Million TWD | 4.18% |
| 2009 | 145.5 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 58.61 Million TWD | 0.67% |
| 2024 Q1 | 61.66 Million TWD | 1.48% |
| 2023 FY | 241.73 Million TWD | 3.54% |
| 2023 Q4 | 60.76 Million TWD | 5.03% |
| 2023 Q3 | 57.85 Million TWD | -8.14% |
| 2023 Q2 | 62.97 Million TWD | 4.72% |
| 2023 Q1 | 60.14 Million TWD | -14.13% |
| 2022 Q2 | 52.52 Million TWD | -2.83% |
| 2022 Q4 | 70.03 Million TWD | 23.17% |
| 2022 FY | 233.47 Million TWD | 11.17% |
| 2022 Q1 | 54.05 Million TWD | -0.75% |
| 2022 Q3 | 56.86 Million TWD | 8.26% |
| 2021 Q1 | 52.69 Million TWD | -1.49% |
| 2021 Q3 | 49.49 Million TWD | -7.27% |
| 2021 Q4 | 54.45 Million TWD | 10.03% |
| 2021 FY | 210.01 Million TWD | -11.5% |
| 2021 Q2 | 53.37 Million TWD | 1.3% |
| 2020 Q1 | 58.7 Million TWD | -5.74% |
| 2020 Q4 | 53.48 Million TWD | -20.4% |
| 2020 Q3 | 67.19 Million TWD | 16.04% |
| 2020 FY | 237.29 Million TWD | 2.46% |
| 2020 Q2 | 57.9 Million TWD | -1.36% |
| 2019 Q2 | 60.16 Million TWD | 11.83% |
| 2019 Q4 | 62.28 Million TWD | 12.5% |
| 2019 FY | 231.6 Million TWD | 7.71% |
| 2019 Q1 | 53.8 Million TWD | -6.78% |
| 2019 Q3 | 55.36 Million TWD | -7.98% |
| 2018 FY | 215.02 Million TWD | 2.87% |
| 2018 Q4 | 57.71 Million TWD | 6.63% |
| 2018 Q3 | 54.12 Million TWD | -2.53% |
| 2018 Q2 | 55.52 Million TWD | 16.49% |
| 2018 Q1 | 47.66 Million TWD | -3.68% |
| 2017 Q4 | 49.48 Million TWD | -8.38% |
| 2017 FY | 209.02 Million TWD | -0.94% |
| 2017 Q2 | 53.36 Million TWD | 2.3% |
| 2017 Q1 | 52.16 Million TWD | 1.83% |
| 2017 Q3 | 54.01 Million TWD | 1.21% |
| 2016 Q2 | 56.49 Million TWD | 3.03% |
| 2016 Q3 | 48.45 Million TWD | -14.24% |
| 2016 FY | 211.01 Million TWD | 6.37% |
| 2016 Q4 | 51.22 Million TWD | 5.72% |
| 2016 Q1 | 54.83 Million TWD | 1.6% |
| 2015 Q3 | 48.04 Million TWD | -2.17% |
| 2015 FY | 198.38 Million TWD | 8.24% |
| 2015 Q1 | 47.25 Million TWD | 16.2% |
| 2015 Q4 | 53.97 Million TWD | 12.33% |
| 2015 Q2 | 49.11 Million TWD | 3.94% |
| 2014 Q1 | 48.43 Million TWD | 21.31% |
| 2014 Q3 | 46.85 Million TWD | -1.02% |
| 2014 FY | 183.28 Million TWD | 0.31% |
| 2014 Q4 | 40.66 Million TWD | -13.21% |
| 2014 Q2 | 47.33 Million TWD | -2.27% |
| 2013 Q1 | 46.32 Million TWD | -1.22% |
| 2013 Q3 | 46.73 Million TWD | -6.04% |
| 2013 Q4 | 39.92 Million TWD | -14.57% |
| 2013 FY | 182.72 Million TWD | 2.77% |
| 2013 Q2 | 49.73 Million TWD | 7.38% |
| 2012 FY | 177.8 Million TWD | 9.92% |
| 2012 Q4 | 46.89 Million TWD | 0.45% |
| 2012 Q3 | 46.68 Million TWD | 8.24% |
| 2012 Q2 | 43.13 Million TWD | 5.7% |
| 2012 Q1 | 40.8 Million TWD | 13.44% |
| 2011 Q1 | 37.94 Million TWD | 10.41% |
| 2011 FY | 161.75 Million TWD | 6.71% |
| 2011 Q4 | 35.97 Million TWD | -19.91% |
| 2011 Q3 | 44.91 Million TWD | 4.63% |
| 2011 Q2 | 42.92 Million TWD | 13.13% |
| 2010 Q1 | 37.41 Million TWD | 0.0% |
| 2010 FY | 151.58 Million TWD | 4.18% |
| 2010 Q2 | 45.47 Million TWD | 21.53% |
| 2010 Q4 | 34.36 Million TWD | 0.15% |
| 2010 Q3 | 34.31 Million TWD | -24.54% |
| 2009 FY | 145.5 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| St.Shine Optical Co.,Ltd. | 374.5 Million TWD | 35.453% |
| Bioteque Corporation | 238.76 Million TWD | -1.244% |
| Chi Sheng Pharma & Biotech Co., Ltd | 281.88 Million TWD | 14.246% |
| Sunder Biomedical Tech. Co., Ltd. | 77.91 Million TWD | -210.254% |
| BenQ Medical Technology Corporation | 978.46 Million TWD | 75.295% |
| Unicon Optical Co., Ltd. | 215.77 Million TWD | -12.027% |
| Formosa Optical Technology Co.,Ltd. | 2.05 Billion TWD | 88.231% |
| Medeon Biodesign, Inc. | 774.36 Million TWD | 68.783% |
| Concord Medical Co., Ltd. | 102.14 Million TWD | -136.65% |
| Crystalvue Medical Corporation | 142.58 Million TWD | -69.533% |
| Perfect Medical Industry Co., Ltd. | 200.55 Million TWD | -20.53% |
| ICARES Medicus, Inc. | 482.4 Million TWD | 49.89% |
| Lagis Enterprise Co., Ltd. | 141.78 Million TWD | -70.491% |
| Amed Co., Ltd. | 385.94 Million TWD | 37.367% |